{
    "title": "Boehringer to pay up to $600 mln for CureVac cancer vaccine",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2760802/Boehringer-pay-600-mln-CureVac-cancer-vaccine.html",
    "date": "2014-09-18",
    "keywords": [
        "cancer",
        "vaccine",
        "gmt",
        "september",
        "lung",
        "deal",
        "curevac",
        "development",
        "cv9202",
        "boehringer",
        "mln",
        "email",
        "ingelheim",
        "firmsthe",
        "drugmaker",
        "thursday",
        "experimental",
        "project",
        "licence",
        "curevacs",
        "developmentunlike",
        "disease",
        "technology",
        "glaxosmithkline",
        "threw",
        "towel",
        "latestage",
        "resultsboehringer",
        "combination",
        "drug",
        "afatinib",
        "chemoradiation",
        "therapy",
        "reporting",
        "ben",
        "hirschler",
        "david",
        "clarke"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}